Trastuzumab (Herceptin)

J.J. Gemmete; S.K. Mukherji

doi:10.3174/ajnr.A2619

Research ArticlePharmacology Vignette

Trastuzumab (Herceptin)

J.J. Gemmete and S.K. Mukherji

American Journal of Neuroradiology September 2011, 32 (8) 1373-1374; DOI: https://doi.org/10.3174/ajnr.A2619

J.J. Gemmete

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

S.K. Mukherji

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
Responses
References
PDF

Article Information

vol. 32 no. 8 1373-1374

DOI

https://doi.org/10.3174/ajnr.A2619

PubMed

21816914

Published By

American Journal of Neuroradiology

Print ISSN

0195-6108

Online ISSN

1936-959X

History

Received February 7, 2011
Accepted after revision February 8, 2011
Published online September 9, 2011.

Author Information

J.J. Gemmetea and
S.K. Mukherjia

^aFrom the Division of Neuroradiology, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan.

Please address correspondence to Joseph J. Gemmete, MD, Department of Radiology, Division of Neuroradiology, UH B1D328, 1500 E Medical Center Dr, Ann Arbor, MI 48109; e-mail: gemmete{at}med.umich.edu

View Full Text

Altmetrics

Cited By...

42 Citations
47 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

SEYUNG S. CHUNG, NOLAN GIEHL, YANYUAN WU, JAYDUTT V. VADGAMA

International Journal of Oncology 2014 44 2
Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis

Asadollahi Parisa, Ghanavati Roya, Rohani Mahdi, Razavi Shabnam, Esghaei Maryam, Talebi Malihe, Salvatore V. Pizzo

PLOS ONE 2020 15 5
Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer

Yiwen You, Zhiyuan Xu, Yun Chen

Drug Delivery 2018 25 1
Charge variant analysis of proposed biosimilar to Trastuzumab

Pravinkumar Dakshinamurthy, Pavithra Mukunda, Bhargav Prasad Kodaganti, Bharath Ravindra Shenoy, Bairavabalakumar Natarajan, Amol Maliwalave, Vivek Halan, Sathyabalan Murugesan, Sunit Maity

Biologicals 2017 46
Evaluation of analytical similarity between trastuzumab biosimilar CT-P6 and reference product using statistical analyses

Jihun Lee, Hyun Ah Kang, Jin Soo Bae, Kyu Dae Kim, Kyoung Hoon Lee, Ki Jung Lim, Min Joo Choo, Shin Jae Chang

mAbs 2018 10 4
Application of aptamer-drug delivery system in the therapy of breast cancer

Rui Fan, Xufeng Tao, Xiaohan Zhai, Yanna Zhu, Yunming Li, Yanwei Chen, Deshi Dong, Shilei Yang, Linlin Lv

Biomedicine & Pharmacotherapy 2023 161
Current Strategies and Applications for Precision Drug Design

Chen Wang, Pan Xu, Luyu Zhang, Jing Huang, Kongkai Zhu, Cheng Luo

Frontiers in Pharmacology 2018 9
Personalized Drug Therapy: Innovative Concept Guided With Proteoformics

Junwen Su, Lamei Yang, Ziran Sun, Xianquan Zhan

Molecular & Cellular Proteomics 2024 23 3
Attenuation of p53 mutant as an approach for treatment Her2-positive cancer

Olga Fedorova, Alexandra Daks, Oleg Shuvalov, Alena Kizenko, Alexey Petukhov, Yulia Gnennaya, Nikolai Barlev

Cell Death Discovery 2020 6 1
Improved Detection of HER2 by a Quasi-Targeted Proteomics Approach Using Aptamer–Peptide Probe and Liquid Chromatography–Tandem Mass Spectrometry

Weixian Zhou, Feifei Xu, Danni Li, Yun Chen

Clinical Chemistry 2018 64 3
Responsive Antibody Conjugates Enable Quantitative Determination of Intracellular Bond Degradation Rate

Michelle R. Sorkin, Joshua A. Walker, Sneha R. Kabaria, Nicole P. Torosian, Christopher A. Alabi

Cell Chemical Biology 2019 26 12
HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor

Lin Ding, Wenxing Gu, Yifan Zhang, Shujing Yue, Huanli Sun, Jeroen J. L. M. Cornelissen, Zhiyuan Zhong

Biomacromolecules 2019 20 10
Cancer-Secreted Exosomal MiR-620 Inhibits ESCC Aerobic Glycolysis via FOXM1/HER2 Pathway and Promotes Metastasis

Yanbo Zhu, Fang Li, Yilong Wan, Hansi Liang, Si Li, Bo Peng, Liqun Shao, Yunyun Xu, Dong Jiang

Frontiers in Oncology 2022 12
Enrichment and Liquid Chromatography–Mass Spectrometry Analysis of Trastuzumab and Pertuzumab Using Affimer Reagents

Oladapo Olaleye, Baubek Spanov, Robert Ford, Natalia Govorukhina, Nico C. van de Merbel, Rainer Bischoff

Analytical Chemistry 2021 93 40
Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors

Parnaz Merikhian, Behrad Darvishi, Neda Jalili, Mohammad Reza Esmailinejad, Azadeh Sharif Khatibi, Shima Moradi Kalbolandi, Malihe Salehi, Marjan Mosayebzadeh, Mahdieh Shokrollahi Barough, Keivan Majidzadeh‐A, Fatemeh Yadegari, Fatemeh Rahbarizadeh, Leila Farahmand

Molecular Oncology 2022 16 2
Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma

Chia-Hsien Shih, Yu-Hua Lin, Hao-Lun Luo, Wen-Wei Sung

Frontiers in Pharmacology 2024 15
Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond

Deepak Kumar, Sulgey Gauthami, Jagadeesh Bayry, Srinivas V. Kaveri, Nagendra R. Hegde

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2021 40 2
Antibody-guided iodinated cyanine for near-IR photoimmunotherapy

Dmytro Kobzev, Olga Semenova, Anatoliy Tatarets, Andrii Bazylevich, Gary Gellerman, Leonid Patsenker

Dyes and Pigments 2023 212
Targeted therapies against breast cancer: Clinical perspectives, obstacles and new opportunities

Diksha Nagpal, Ravinder Verma, Vineet Mittal, Philippe Jeandet, Deepak Kaushik

Journal of Drug Delivery Science and Technology 2023 89
Biosimilar monoclonal antibodies for cancer treatment

Taís F Galvão, Annemeri Livinalli, Luciane C Lopes, Ivan R Zimmermann, Marcus T Silva

Cochrane Database of Systematic Reviews 2020
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplification

Umut Disel, Alexis Germain, Bahar Yilmazel, Huseyin Abali, Filiz Aka Bolat, Roman Yelensky, Julia A. Elvin, Doron Lipson, Juliann Chmielecki, Kai Wang, Philip J. Stephens, Jeffrey S. Ross, Vincent A. Miller, Siraj M. Ali, Thomas J. George Jr.

Oncoscience 2015 2 6
African Vegetables (Clerodendrum volubile Leaf and Irvingia gabonensis Seed Extracts) Effectively Mitigate Trastuzumab-Induced Cardiotoxicity in Wistar Rats

Olufunke Olorundare, Adejuwon Adeneye, Akinyele Akinsola, Sunday Soyemi, Alban Mgbehoma, Ikechukwu Okoye, James M. Ntambi, Hasan Mukhtar, Demetrios Kouretas

Oxidative Medicine and Cellular Longevity 2020 2020
Aptamer-based sample purification for mass spectrometric quantification of trastuzumab in human serum

Bo Sun, Jiuyang Liu, Pei Cai, Jianhua Wu, Wei Liu, Hankun Hu, Liang Liu

Talanta 2023 257
Design Rules for Antibody Delivery by Self-Assembled Block-Copolyelectrolyte Nanocapsules

Sousa Javan Nikkhah, Pierre A. Cazade, Jennifer J. McManus, Damien Thompson

Macromolecules 2022 55 7
An Antibody‐CRISPR/Cas Conjugate Platform for Target‐Specific Delivery and Gene Editing in Cancer

Seungju Yang, San Hae Im, Ju Yeon Chung, Juhee Lee, Kyung‐Hun Lee, Yoo Kyung Kang, Hyun Jung Chung

Advanced Science 2024 11 21
Molecular dynamic simulation of Trastuzumab F(ab’)2structure in corporation with HER2 as a theranostic agent of breast cancer

S Hermanto, M Yusuf, A Mutalib, S Hudiyono

Journal of Physics: Conference Series 2017 835
Present and Future of Immunotherapy for Triple-Negative Breast Cancer

Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers, Shyam Nyati

Cancers 2024 16 19
Polyglycerol-Shelled Reduction-Sensitive Polymersome for DM1 Delivery to HER-2-Positive Breast Cancer

Guoxin Ma, Daniel Braatz, Peng Tang, Yian Yang, Elisa Quaas, Kai Ludwig, Nan Ma, Huanli Sun, Zhiyuan Zhong, Rainer Haag

Biomacromolecules 2024 25 7
Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer

Maëva Lion, Alexandre Harlé, Julia Salleron, Carole Ramacci, Mario Campone, Jean-Louis Merlin

Oncology Letters 2016 12 3
A Research Journey: Over a Decade of Denaturing and Native-MS Analyses of Hydrophobic and Membrane Proteins in Amgen Therapeutic Discovery

Iain D. G. Campuzano

Journal of the American Society for Mass Spectrometry 2023 34 10
Cardiotoxicity in patients on trastuzumab in HER2-positive breast cancer – A retrospective analysis from a center in North India

Anjali Aggarwal, Pratik Patil, Ranga Rao Rangaraju, Waseem Abbas, Sunny Garg

International Journal of Molecular and Immuno Oncology 2021 6
Distribution of Breast Cancer Biomarkers by Age in Iran

Hassan Akbari, Farzad Taghizadeh Hesary, Laya Rahnar Nikoukar

Journal of Analytical Oncology 2017 6 1
LGR5 is a biomarker for stratification of HER-2 positive breast cancer patients and personalized treatment

Chan Chen, Cheng Zhang, Jun-Mei Xu, Yong Han

Medical Hypotheses 2013 81 3
Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer

Sa Deok Hong, Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Seong Min Park, Tae Hoen Kim, Young Seok Baek, Seung Ryeol Lee, Yong Wha Moon

International Journal of Molecular Sciences 2024 25 21
Adjuvant Trastuzumab Plus Pertuzumab Versus Trastuzumab Alone in Patients Achieving Pathologic Complete Response After Chemotherapy With Trastuzumab and Pertuzumab: A Retrospective Cohort Study

Yoonwon Kook, Jee Hung Kim, Ji Soo Jang, Soong June Bae, Seung Ho Baek, Joon Jeong, Joon Young Choi, Dong Seung Shin, Jai Min Ryu, Sung Gwe Ahn

Clinical Breast Cancer 2025 25 2
Biosimilar monoclonal antibodies for cancer treatment in adults

Tais F Galvao, Annemeri Livinalli, Luciane C Lopes, Ivan R Zimmermann, Marcus Tolentino Silva

Cochrane Database of Systematic Reviews 2024 2024 11
Effects of trastuzumab emtansine on canine urothelial carcinoma cells in vitro and in vivo

Kosei Sakai, Daiki Kato, Junka Yoshinaka, Yosuke Takahashi, Namiko Ikeda, Susumu Aoki, Takaaki Iguchi, Shingo Ishikawa, Norio Yamagishi, Shunsuke Shimamura, Takayuki Nakagawa

Veterinary and Comparative Oncology 2024 22 2
Herceptin cardiotoxicity and delayed breast reconstruction surgery

Ammar Allouni, Elizabeth Wharton, Thomas Collin

Journal of Plastic, Reconstructive & Aesthetic Surgery 2014 67 11
Navigating the future: Advancements in monoclonal antibody nanoparticle therapy for cancer

Harshad Kapare, Mayuri Bhosale, Ritesh Bhole

Journal of Drug Delivery Science and Technology 2025 104
Pharmacotherapy considerations in patients who develop acute kidney injury during anti-cancer therapy

Emanuele Parodi, Maura Rossi, Achille Bottiglieri, Marco Ladetto, Guido Merlotti, Vincenzo Cantaluppi, Marco Quaglia

Expert Opinion on Pharmacotherapy 2024 25 5
Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer

Debanjan Mukherjee, Sarjana Raikwar

AAPS PharmSciTech 2024 25 6
Combined nanotechnology with monoclonal antibody drugs for cancer immunotherapy

Wenqing Fan

Highlights in Science, Engineering and Technology 2024 102
Effects of trastuzumab emtansine on canine osteosarcoma cells

Kosei SAKAI, Daiki KATO, Junka YOSHINAKA, Muneki HONNAMI, Yosuke TAKAHASHI, Namiko IKEDA, Susumu AOKI, Takaaki IGUCHI, Qin SHIYU, Miki ANDO, Satoshi KAMESHIMA, Shunsuke SHIMAMURA, Takayuki NAKAGAWA

Journal of Veterinary Medical Science 2025 87 5
Genetic-bioengineering of nanotechnology in cell-specific pharmaceutical targeting: Biological, pharmacological, and biochemical impact of nanomaterials-based breast cancer therapies

Javad Mohammadi, Sina Ebrahimi, Maryam Ghodousi, Mohammadreza Mahmoodi, Ali Hheidari, Esmail Pishbin, Zelal Kharaba, Abbas Rahdar, Luiz Fernando Romanholo Ferreira

Journal of Drug Delivery Science and Technology 2024 101
Overcoming Cancers Resistant to HER-2 Antibodies

Ryan McWhorter, Massimo Libra, Benjamin Bonavida

2024
Oxidative Stress in Heart Diseases

Thalita Basso Scandolara, Bruno Ricardo Pires, Rodrigo Kern, Vanessa Jacob Victorino, Carolina Panis

2019
Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer

Yi-Wen Wang, Yih-Lin Tuan, Jiu-Yao Wang, Hong-Yi Chang, Chien-An Chu, Yi-Lin Chen, Hui-Wen Chen, Chung-Liang Ho, Chung-Ta Lee, Nan-Haw Chow

Oncology Reports 2024 53 1

PreviousNext

In this issue

American Journal of Neuroradiology

Vol. 32, Issue 8

1 Sep 2011

Table of Contents
Index by author

Download PDF

Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Trastuzumab (Herceptin)

Message Subject (Your Name) has sent you a message from American Journal of Neuroradiology

Message Body (Your Name) thought you would like to see the American Journal of Neuroradiology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cite this article

J.J. Gemmete, S.K. Mukherji

Trastuzumab (Herceptin)

American Journal of Neuroradiology Sep 2011, 32 (8) 1373-1374; DOI: 10.3174/ajnr.A2619

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

0 Responses

Respond to this article

Bookmark this article

User Name *

Password *

Remember my user name & password.

Trastuzumab (Herceptin)

J.J. Gemmete, S.K. Mukherji

American Journal of Neuroradiology Sep 2011, 32 (8) 1373-1374; DOI: 10.3174/ajnr.A2619

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Purchase

Jump to section

Article
Figures & Data
Info & Metrics
Responses
References
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

3D Culture Represents Apoptosis Induced by Trastuzumab Better than 2D Monolayer Culture
Improved Detection of HER2 by a Quasi-Targeted Proteomics Approach Using Aptamer-Peptide Probe and Liquid Chromatography-Tandem Mass Spectrometry

Crossref (47)
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

SEYUNG S. CHUNG, NOLAN GIEHL, YANYUAN WU, JAYDUTT V. VADGAMA

International Journal of Oncology 2014 44 2
Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis

Asadollahi Parisa, Ghanavati Roya, Rohani Mahdi, Razavi Shabnam, Esghaei Maryam, Talebi Malihe, Salvatore V. Pizzo

PLOS ONE 2020 15 5
Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer

Yiwen You, Zhiyuan Xu, Yun Chen

Drug Delivery 2018 25 1
Charge variant analysis of proposed biosimilar to Trastuzumab

Pravinkumar Dakshinamurthy, Pavithra Mukunda, Bhargav Prasad Kodaganti, Bharath Ravindra Shenoy, Bairavabalakumar Natarajan, Amol Maliwalave, Vivek Halan, Sathyabalan Murugesan, Sunit Maity

Biologicals 2017 46
Evaluation of analytical similarity between trastuzumab biosimilar CT-P6 and reference product using statistical analyses

Jihun Lee, Hyun Ah Kang, Jin Soo Bae, Kyu Dae Kim, Kyoung Hoon Lee, Ki Jung Lim, Min Joo Choo, Shin Jae Chang

mAbs 2018 10 4
Application of aptamer-drug delivery system in the therapy of breast cancer

Rui Fan, Xufeng Tao, Xiaohan Zhai, Yanna Zhu, Yunming Li, Yanwei Chen, Deshi Dong, Shilei Yang, Linlin Lv

Biomedicine & Pharmacotherapy 2023 161
Current Strategies and Applications for Precision Drug Design

Chen Wang, Pan Xu, Luyu Zhang, Jing Huang, Kongkai Zhu, Cheng Luo

Frontiers in Pharmacology 2018 9
Personalized Drug Therapy: Innovative Concept Guided With Proteoformics

Junwen Su, Lamei Yang, Ziran Sun, Xianquan Zhan

Molecular & Cellular Proteomics 2024 23 3
Attenuation of p53 mutant as an approach for treatment Her2-positive cancer

Olga Fedorova, Alexandra Daks, Oleg Shuvalov, Alena Kizenko, Alexey Petukhov, Yulia Gnennaya, Nikolai Barlev

Cell Death Discovery 2020 6 1
Improved Detection of HER2 by a Quasi-Targeted Proteomics Approach Using Aptamer–Peptide Probe and Liquid Chromatography–Tandem Mass Spectrometry

Weixian Zhou, Feifei Xu, Danni Li, Yun Chen

Clinical Chemistry 2018 64 3

Main menu

User menu

Search

American Journal of Neuroradiology

Trastuzumab (Herceptin)

Article Information

Author Information

Altmetrics

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Indexed Content

Cases

Special Collections

Resources

Multimedia

About Us

American Society of Neuroradiology